London South East | The UK's favourite investor portal.

Nobody expected to hear about any licencing deals etc, we get its a scientific conference, but of the 100s of people, experts in the field, educated individuals with their own private investment portfolios, self managed pensions etc. You would like to think a few of those people would listen to Dr Sandler and think "This sounds promising, I will have to look when I get home, might be worth an investment!". When you consider how minuscule the daily volume is here and the tiny mCap only a couple of new investors would be noticed. But.... nothing on the volume side so either nobody liked what they saw enough to give them the urge to invest, or they did but went home to investigate further and found an ancient website with zero useful information on it, or maybe it takes time for individuals to invest. Either way, so far results disappointing.

I have attended conferences (Infosec/technology not Biomedical) in the past as a guest of a presenting company and was that impressed with one presentation from a different company I went home and made a small investment. The people that attend these conferences, its immaterial if they are representing a company or not, they are real people with ambitions and probably a surplus income and if they are wowed they will dip into their own pockets. Maybe interest will build from the conference, I certainly hope so:
"a great opportunity to inform the scientific, industrial and *investment communities* about our achievements and increase the Company's visibility globally." - Dr Vladislav Sandler, CEO & Co-Founder of Hemogenyx Pharmaceuticals.

In terms of staff turnover - Its natural, I worked at a startup, I was number 4 though the door and had a huge say in the early days and sense of ownership despite being very junior. When it turned into a success and work moved more from green field to support and maintenance I moved on having climbed rapidly with its growth, not because of lack of belief but because it felt like job done and wanted something more exciting again. I am sure those who have left will have shares, probably some long term incentive scheme so when the company does finally shine they will be rewarded. They were there at the start, they helped discover and develop CAR-T, CBR, CAR-NK, CDX etc, but the initial thrill of discovery wears off. Plus its America... people move jobs ALOT and while in the UK we give normally 1month+ notice, does not happen over there people just walk.....

MrIndia, I support some of what you say, it is very hard to get new investors because most have no clue what this company is about or what is coming. With lack of noise from the company themselves sites like this get more attention than they should so negative voices here become sometimes the loudest when searching for news on Hemogenyx.
I semi agree about how the company is run, I have a list of issues which are decisions or actions or lack of actions which have been detrimental to the share price and value for investors over the years which I will take up with Vlad but those issues are only relevant because Hemogenyx is public. As a scientific research company developing IP with the intent of saving lives and producing treatments that will be worth billions they have done everything right. Maintained ownership of IP, maximising value for money, keeping as much of the processes in house. Internally the discipline has been exemplary but this is not reflected in the share price.

Anyway, people have been getting very irate and active the past few days when Vlad has been sat listening to other people present. Its today he presents and will be meeting people today and tomorrow so might I advise people to chill and see what the next few days bring.

Fundamentally though, Mr Penguin is right, as we stand cash is king, its a bear market, full fear, capitulation up the wazoo. Nobody is buying stocks, the boards are and have been red for a very considerable time, pick a small stock over the past 6 months and its probably red. Either the market will break and we have a relief rally or Hemogenyx will get enough momentum to break up irrespective, one of the 2 will happen. Both are well overdue :-)

Socialist, just for more clarification, reading though the documentation and interviews etc to try and understand how its possible to have such a wide and crazy claim and it does seem to stack up. Whats not obvious is can vlad REALLY IP protect this whole set up.
So from my EXTREMELY basic understanding you can attack and destroy a virus/bacteria/cell by identifying it and attacking it, so say identifying the Spike protein on Covid-19 may release cytokines which attack, or antibodies may swarm and neutralise a cell or helper cells may bind to the foreign invading cell and bind it to say a B-Cell etc. Basically all these methods rely on identifying the foreign cell then using some form of attack. The cells that are easily identified and killed die off and mutations to say spike proteins that avoid detection go on to become dominant. Or cells that have a membrane that protect against some new antibody will survive and pass on that immunity. But they all need to be identified by the hosts immune system to be killed is the key factor.
What they all have in common is that they attack target cells by expressing proteins that bind to receptors on the healthy cells. Our human DNA based cells dont mutate, and whilst the invading pathogen might mutate it does not matter as any mutation that prevents it from binding to the CBR means it also cannot bind to healthy cells which is necessary to replicate.
The CBR probably attaches a receptor bait to I am going to guess macrophage but could be a number of cells, that will allow the pathogen to bind. I had a look at the proteins that can bind on Covid-19 and they are not a million miles away from measles or MRSA etc.

And even better, these cells can kill multiple pathogens, they swallow up the pathogen using the receptors to bind, they trap it in a vesicle but then the receptors return to the surface to go again, they dont die or disappear, REDUCE, REUSE, RECYCLE.

As a concept when you look for flaws, there are none, perhaps the cost of treatment, but when you consider when you go to the GP and you hear 2 things:
Its probably a virus there is nothing we can do for you just bed rest and fluids
and
We cant prescribe antibiotics, we are running out and they are not working any more.

Its hard to imagine that CBR wont start to prick some ears soon.

MrIndia, it is unhealthy to spend too much time watching, right now your seeing a red share price and feeling anxious when the reality is there is like 380k worth of sells and 1.16m buys (dhub i think the 240k is a buy personally). How many times have you seen the MMS move the price around to get people to buy or sell without actually changing the price? Try and focus on the bigger picture, when its tiny amounts like this its completely irrelevant.
PK, I dont think we expect this week to deliver the billions, I agree with you about any large investment decisions being unlikely, IMO any large investment decision by pharma will not be buying on main market anyway. But as seen this morning, the SP moves on < 1m shares. Vlad is not just speaking to the companies tomorrow morning, he is speaking to a room of potential investors many from the UK. I understand outside of that presentation he is also speaking to other investors again from the UK.
The argument I have frequently with people is that many of those with a negative standpoint here base that on a poor share price and a demand for additional news while refusing to look at what we already have vs the existing Share Price. Something that I HOPE and also believe experienced investors will do when they finally hear about Hemogenyx. When you take away the cash position we have a valuation of sub £10mil for Hemogenyx. That is in spite of the fact they have:
Hu-PHEC :Shelved but IP is owned and massive potential, still valuable
ApbHC : Not mentioned as much but with HvG benifits still valuable
CDX: "ready for IND-enabling studies, the final step before applying for a licence to conduct clinical trials." - CDX should attract significant interest from financial or strategic partners
CAR-T: now at an advanced stage of completing our application for IND status. expect to be in a position scientifically to commence trials once the IND designation has been granted.
CBR: modular synthetic receptors that can be rapidly reconfigured to attack almost any virus, bacteria, or malignant cells.

I get the negativity of some because of the share price, but do people get why you frustrate me when you focus on the SP?

Hemogenyx are sitting on CDX: A potential replacement for Chemotherapy NOT JUST for AML but for ALOT of conditions, Chemo makes treatment impossible for many patients.
CBR: Cure for some cancers and Covid-19 right now... BUT... ALMOST ANY Virus/Bacteria/cells???? We are talking about a whole new range of antibiotics here in a world terrified of MRSA becoming super resistant to the last remaining antibiotics!

If even a fraction of what Vlad is offering here comes to fruition this company WILL be worth billions. So please, give over about someone selling 5k worth of shares, they are idiots :P

Latest Share Chat

Member Info for JustHereForHemo

Followers

Following

Posts (Last 30 Days)

Posts (All Time)

Last Post

Member Since

Share Chat Post Distribution (Last 30 Days)

Activity Log (Last 30 Days)